English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Aids Institute
John Breslin
| Oct 27, 2017
CMS administrator urged to prevent states from restricting hepatitis C drug access
Nicholas Gueguen
| Aug 13, 2017
House Appropriations Committee decides to keep funding for several programs in HIV, hepatitis fight
Robert Hadley
| Jun 2, 2017
FDA approves higher once-a-day dose of Merck’s Isentress HIV drug
Erianne Leatherman
| May 16, 2017
AIDS Alliance working with Advocates for Youth to boost AIDS/HIV awareness
Erianne Leatherman
| Mar 15, 2017
Updates to National Viral Hepatitis Action Plan include strategies to prevent infection
Vimbai Chikomo
| Apr 6, 2016
Obamacare is failing to discipline Florida insurers for discriminating against hepatitis C patients, according to expert
Jamie Barrand
| Dec 24, 2015
The AIDS Institute officials laud rejection of HIV funding cuts
Katelyn Kivel
| Nov 3, 2015
Cigna leaves Florida exchange amid HIV discrimination allegations
Trending
+
Regulatory
C.D. Marsden
| Apr 12, 2025
Empower Pharmacy: Eli Lilly lawsuit is ‘Big Pharma’s attempt to limit patient and provider choice’
+
Pharmaceuticals
Patient Daily
| Apr 10, 2025
Researchers uncover mechanisms behind metabolic demands in nursing mothers
+
Pharmaceuticals
Patient Daily
| Apr 15, 2025
UCSF neurosurgeon: '340B is a drug discount program that hospitals exploit as an additional revenue stream'
+
Pharmaceuticals
Patient Daily
| Apr 15, 2025
Former Domestic Policy Council director: 340B program turns large non-profit hospitals into 'pure profit' centers
